Stay updated on M2951 in SLE Phase II Clinical Trial
Sign up to get notified when there's something new on the M2951 in SLE Phase II Clinical Trial page.
Latest updates to the M2951 in SLE Phase II Clinical Trial page
- Check6 days agoChange DetectedLocations section expanded and reorganized to include new sites across the US and international locations (Argentina, Italy, Japan, Malaysia, Mexico, South Africa, etc.) with a new revision tag v3.3.3. The previous location listing has been updated to reflect the current trial sites.SummaryDifference2%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe Publications section description was updated to indicate publications are automatically filled from PubMed, and the PubMed-related wording was revised; the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.0%
- Check42 days agoChange DetectedRemoved the general government funding/operating status notice at the top of the page, including references to cc.nih.gov and opm.gov.SummaryDifference0.1%
- Check58 days agoChange DetectedNo additions or deletions were identified on the page.SummaryDifference0.1%
- Check86 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference1.0%
- Check94 days agoChange DetectedAdds a new version label (v3.1.0) and removes multiple drug-related topics, indicating a restructuring and potential narrowing of content.SummaryDifference0.1%
Stay in the know with updates to M2951 in SLE Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M2951 in SLE Phase II Clinical Trial page.